Official account of Prof. Elizabeth Winzeler's Lab at UC San Diego | Drug discovery, target ID, resistance mechanisms, and host-pathogen interactions of malaria
Hot off the press! We have identified and characterized MFR3, a novel multidrug resistance mediator in P. falciparum. Read all about it in @ACS_Infectious:
pubs.acs.org/doi/10.1021/acs…
Calling all parasitology trainees! @acmcip is running a free workshop titled “Science Communication in the Time of COVID19” on Thursday, July 23 at 4pm EDT (GMT-4). Register here: docs.google.com/forms/d/e/1F…. #ACMCIPtrainees
Good news for the #malaria community!🎉
MMV is launching Malaria Libre, an open-source & collaborative drug discovery platform to accelerate innovation. 🔬💊
Join the open-innovation revolution: bit.ly/3e0LVMU
Imidazolopiperazine compounds are under clinical development for #malaria. Here the authors show that the compounds inhibit the parasite's secretory pathway, affecting protein trafficking & export
@WinzelerLabUCSD@fidocklab @ElizabethWinze1 @afcowmango.nature.com/2Yg4hoC
Imidazolopiperazine compounds are under clinical development for #malaria. Here the authors show that the compounds inhibit the parasite's secretory pathway, affecting protein trafficking & export
@WinzelerLabUCSD@fidocklab @ElizabethWinze1 @afcowmango.nature.com/2Yg4hoC
@ElizabethWinze1 kicks off day 3 and the drug development session by telling us about stories from the Malaria Drug Accelerator (MalDA), a multinational drug discovery program funded by @gatesfoundation#MAM2020